Comparison between Gland Pharma IPO and Mazagon Dock Shipbuilders IPO.
Gland Pharma IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Mazagon Dock Shipbuilders IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Mazagon Dock Shipbuilders IPO is up to ₹443.69 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Mazagon Dock Shipbuilders IPO is ₹145.00 per share.
| Gland Pharma IPO | Mazagon Dock Shipbuilders IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,490.00 per share | ₹135.00 per share |
| Issue Price (Upper) | ₹1,500.00 per share | ₹145.00 per share |
| Issue Price (Final) | ₹1,500.00 per share | ₹145.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 10 shares | 103 shares |
| Fresh Issue Size | 83,33,333 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹1,250.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,48,63,635 shares | 3,05,99,017 shares |
| OFS Issue Size (Amount) | up to ₹5,229.55 Cr | up to ₹443.69 Cr |
| Issue Size Total | 4,31,96,968 shares | 3,05,99,017 shares |
| Issue Size Total (Amount) | up to ₹6,479.55 Cr | up to ₹443.69 Cr |
Gland Pharma IPO opens on Nov 09, 2020, while Mazagon Dock Shipbuilders IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Mazagon Dock Shipbuilders IPO is Nov 11, 2020, and Oct 01, 2020, respectively.
| Gland Pharma IPO | Mazagon Dock Shipbuilders IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2020 | |
| Issue Open | Nov 09, 2020 | Sep 29, 2020 |
| Issue Close | Nov 11, 2020 | Oct 01, 2020 |
| Basis Of Allotment (Tentative) | Nov 17, 2020 | Oct 07, 2020 |
| Initiation of Refunds (Tentative) | Nov 18, 2020 | Oct 08, 2020 |
| Credit of Share (Tentative) | Nov 19, 2020 | Oct 09, 2020 |
| Listing date (Tentative) | Nov 20, 2020 | Oct 12, 2020 |
| Anchor Lockin End date 1 | Dec 17, 2020 | |
| Anchor Lockin End date 2 | Feb 15, 2021 |
Gland Pharma IPO P/E ratio is , as compared to Mazagon Dock Shipbuilders IPO P/E ratio of .
| Gland Pharma IPO | Mazagon Dock Shipbuilders IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 74 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 58 | 85 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹24492.42 Cr. | ₹2924.51 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Gland Pharma IPO Retail Individual Investors (RII) are offered 1,51,18,939 shares while in Mazagon Dock Shipbuilders IPO retail investors are offered 1,51,18,939 shares. Qualified Institutional Buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 1,51,26,750 shares in Mazagon Dock Shipbuilders IPO.
| Gland Pharma IPO | Mazagon Dock Shipbuilders IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,59,089 shares | |
| Market Maker Reservation | ||
| QIB | 86,39,394 shares | 1,51,26,750 shares |
| NII | 64,79,546 shares | 45,38,025 shares |
| RII | 1,51,18,939 shares | 1,05,88,725 shares |
| Employee | 3,45,517 shares | |
| Others | ||
| Total | 4,31,96,968 shares | 3,05,99,017 shares |
Gland Pharma IPO subscribed 2.06x in total, whereas Mazagon Dock Shipbuilders IPO subscribed 157.41x.
| Gland Pharma IPO | Mazagon Dock Shipbuilders IPO | |
|---|---|---|
| QIB (times) | 6.40x | 89.71x |
| NII (times) | 0.51x | 678.88x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.24x | 35.63x |
| Employee (times) | 3.88x | |
| Other (times) | ||
| Total (times) | 2.06x | 157.41x |
